1. Home
  2. BOLT vs CKX Comparison

BOLT vs CKX Comparison

Compare BOLT & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • CKX
  • Stock Information
  • Founded
  • BOLT 2015
  • CKX 1930
  • Country
  • BOLT United States
  • CKX United States
  • Employees
  • BOLT N/A
  • CKX N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • CKX Oil & Gas Production
  • Sector
  • BOLT Health Care
  • CKX Energy
  • Exchange
  • BOLT Nasdaq
  • CKX Nasdaq
  • Market Cap
  • BOLT 25.3M
  • CKX 25.6M
  • IPO Year
  • BOLT 2021
  • CKX 1998
  • Fundamental
  • Price
  • BOLT $0.57
  • CKX $12.63
  • Analyst Decision
  • BOLT Hold
  • CKX
  • Analyst Count
  • BOLT 5
  • CKX 0
  • Target Price
  • BOLT $1.25
  • CKX N/A
  • AVG Volume (30 Days)
  • BOLT 126.9K
  • CKX 994.0
  • Earning Date
  • BOLT 11-12-2024
  • CKX 01-01-0001
  • Dividend Yield
  • BOLT N/A
  • CKX N/A
  • EPS Growth
  • BOLT N/A
  • CKX N/A
  • EPS
  • BOLT N/A
  • CKX 0.22
  • Revenue
  • BOLT $9,779,000.00
  • CKX $2,030,981.00
  • Revenue This Year
  • BOLT $16.30
  • CKX N/A
  • Revenue Next Year
  • BOLT N/A
  • CKX N/A
  • P/E Ratio
  • BOLT N/A
  • CKX $56.17
  • Revenue Growth
  • BOLT 35.86
  • CKX 88.35
  • 52 Week Low
  • BOLT $0.55
  • CKX $12.21
  • 52 Week High
  • BOLT $1.56
  • CKX $14.44
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 29.99
  • CKX 31.22
  • Support Level
  • BOLT $0.63
  • CKX $12.63
  • Resistance Level
  • BOLT $0.69
  • CKX $13.01
  • Average True Range (ATR)
  • BOLT 0.03
  • CKX 0.16
  • MACD
  • BOLT -0.01
  • CKX -0.03
  • Stochastic Oscillator
  • BOLT 3.49
  • CKX 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership in the form of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields.

Share on Social Networks: